Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells
about
The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the futurePD-1/CTLA-4 Blockade Inhibits Epstein-Barr Virus-Induced Lymphoma Growth in a Cord Blood Humanized-Mouse ModelExpression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinomaEnhancement of adenovirus vector entry into CD70-positive B-cell Lines by using a bispecific CD70-adenovirus fiber antibodyEpstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinomaTargeting pancreatic and ovarian carcinomas using the auristatin-based anti-CD70 antibody-drug conjugate SGN-75Control of the inflammatory response mechanisms mediated by natural and induced regulatory T-cells in HCV-, HTLV-1-, and EBV-associated cancers.T cells redirected against CD70 for the immunotherapy of CD70-positive malignanciesHigh serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.Pancreatic ductal adenocarcinoma: a review of immunologic aspects.Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.Immunotherapy targets in pediatric cancer.Epstein-Barr virus lytic transactivator Zta enhances chemotactic activity through induction of interleukin-8 in nasopharyngeal carcinoma cells.CD70 (TNFSF7) is expressed at high prevalence in renal cell carcinomas and is rapidly internalised on antibody binding.Molecular mechanism and function of CD40/CD40L engagement in the immune system.c-Myc and EBV-LMP1: two opposing regulators of the HLA class I antigen presentation machinery in epithelial cellsTargeted alpha therapy using a novel CD70 targeted thorium-227 conjugate in in vitro and in vivo models of renal cell carcinoma.Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.The Microenvironment in Epstein-Barr Virus-Associated Malignancies.Hypoxia-inducible factor-2 alpha up-regulates CD70 under hypoxia and enhances anchorage-independent growth and aggressiveness in cancer cells.
P2860
Q24673258-3B851451-2AF0-4350-9AB4-AD690E939C16Q27313748-17004B71-A9C6-425E-A3E4-7CCF2F4816D3Q33285706-23F94F6B-8848-4898-A884-B23950CBCE39Q33851887-66012053-A716-405B-9B82-4641F187946CQ34089491-50B2EC3F-4D5F-45DB-804A-E862632A8337Q34122802-A5EA9B30-C2C0-4AD3-9832-D2B6AD5A93BDQ34708248-62E29C6F-BA49-4288-AD05-25E81E67E925Q34923799-087657B1-48BA-4DEF-9F55-22A2CA547B0EQ35674802-087DDDDF-ECF1-41D9-92A0-677FC7A9FBBDQ35870682-C735B1C3-FA21-4017-B083-2A186E6C406EQ35873657-85D263BE-BFC9-4210-9D52-60DE03D0E4D0Q35971029-C17C4152-E9B4-4AF8-8EE0-8FB02FA22FCFQ36498181-35942C5F-437F-489F-B670-23BA18002C74Q36612144-83D8FCE2-9575-461D-9535-7F12F802AC91Q37474929-6D407506-39DC-40B9-9CE0-E4F12E4EC75CQ39347865-5D5BED05-1B63-499B-B4AC-8ED86DF2BDC3Q41346916-DDCD3C7A-F4A8-4F14-BE16-609D91CFC6C7Q44638209-DD5D72B7-2C6B-4160-BDFD-02D201DB5340Q54236409-2E131575-11CB-4857-AD25-8ECB3066338FQ55006840-6E272BB2-5ABC-4055-AACA-EE3CF32B2EFF
P2860
Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Expression of immune regulator ...... nd infiltrating lymphoid cells
@en
type
label
Expression of immune regulator ...... nd infiltrating lymphoid cells
@en
prefLabel
Expression of immune regulator ...... nd infiltrating lymphoid cells
@en
P2093
P2860
P1476
Expression of immune regulator ...... nd infiltrating lymphoid cells
@en
P2093
P2860
P304
P407
P577
1995-10-01T00:00:00Z